115 related articles for article (PubMed ID: 8545116)
1. Sequential molecular genetic changes in lung cancer development.
Chung GT; Sundaresan V; Hasleton P; Rudd R; Taylor R; Rabbitts PH
Oncogene; 1995 Dec; 11(12):2591-8. PubMed ID: 8545116
[TBL] [Abstract][Full Text] [Related]
2. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
3. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus.
Sundaresan V; Ganly P; Hasleton P; Rudd R; Sinha G; Bleehen NM; Rabbitts P
Oncogene; 1992 Oct; 7(10):1989-97. PubMed ID: 1408139
[TBL] [Abstract][Full Text] [Related]
4. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
5. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions.
Sozzi G; Miozzo M; Pastorino U; Pilotti S; Donghi R; Giarola M; De Gregorio L; Manenti G; Radice P; Minoletti F
Cancer Res; 1995 Jan; 55(1):135-40. PubMed ID: 7805023
[TBL] [Abstract][Full Text] [Related]
6. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.
Sozzi G; Miozzo M; Donghi R; Pilotti S; Cariani CT; Pastorino U; Della Porta G; Pierotti MA
Cancer Res; 1992 Nov; 52(21):6079-82. PubMed ID: 1394234
[TBL] [Abstract][Full Text] [Related]
7. Clonal evolution of lung tumors.
Chung GT; Sundaresan V; Hasleton P; Rudd R; Taylor R; Rabbitts PH
Cancer Res; 1996 Apr; 56(7):1609-14. PubMed ID: 8603409
[TBL] [Abstract][Full Text] [Related]
8. Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer.
Kok K; Osinga J; Carritt B; Davis MB; van der Hout AH; van der Veen AY; Landsvater RM; de Leij LF; Berendsen HH; Postmus PE
Nature; 1987 Dec 10-16; 330(6148):578-81. PubMed ID: 2825033
[TBL] [Abstract][Full Text] [Related]
9. Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.
Shigemitsu K; Sekido Y; Usami N; Mori S; Sato M; Horio Y; Hasegawa Y; Bader SA; Gazdar AF; Minna JD; Hida T; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Shimokata K
Oncogene; 2001 Jul; 20(31):4249-57. PubMed ID: 11464291
[TBL] [Abstract][Full Text] [Related]
10. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.
Wistuba II; Behrens C; Milchgrub S; Bryant D; Hung J; Minna JD; Gazdar AF
Oncogene; 1999 Jan; 18(3):643-50. PubMed ID: 9989814
[TBL] [Abstract][Full Text] [Related]
11. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
[TBL] [Abstract][Full Text] [Related]
12. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
13. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
Cairns P; Okami K; King P; Bonacum J; Ahrendt S; Wu L; Mao L; Jen J; Sidransky D
Cancer Res; 1997 Dec; 57(23):5356-9. PubMed ID: 9393760
[TBL] [Abstract][Full Text] [Related]
14. Paraffin wax-embedded material as a source of DNA for the detection of somatic genetic changes.
Sundaresan V; Ganly P; Hasleton P; Bleehen NM; Rabbitts P
J Pathol; 1993 Jan; 169(1):43-52. PubMed ID: 8094433
[TBL] [Abstract][Full Text] [Related]
15. Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3.
Güre AO; Altorki NK; Stockert E; Scanlan MJ; Old LJ; Chen YT
Cancer Res; 1998 Mar; 58(5):1034-41. PubMed ID: 9500467
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of apc mutation.
Cooper CA; Bubb VJ; Smithson N; Carter RL; Gledhill S; Lamb D; Wyllie AH; Carey FA
J Pathol; 1996 Sep; 180(1):33-7. PubMed ID: 8943812
[TBL] [Abstract][Full Text] [Related]
18. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene.
Sekido Y; Ahmadian M; Wistuba II; Latif F; Bader S; Wei MH; Duh FM; Gazdar AF; Lerman MI; Minna JD
Oncogene; 1998 Jun; 16(24):3151-7. PubMed ID: 9671394
[TBL] [Abstract][Full Text] [Related]
19. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations.
Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD
Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease.
Angeloni D
Brief Funct Genomic Proteomic; 2007 Mar; 6(1):19-39. PubMed ID: 17525073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
